Femtech company offering at-home vaginal microbiome testing via a tampon kit.
| Date | Round | Amount |
|---|---|---|
| Oct 2022 | Series A London femtech Daye raised a 10M GBP Series A for its at-home vaginal microbiome testing kit. | $11.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.